Company Information
USD
6.97
- (1.2%)
NASDAQ:CAPR, CAPRICOR THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 8 May 2025 GMT-4
Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.
Address
10865 Road to the Cure
Suite 150
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Dr. Philip Gotwals,PhD
Director
Dr. Paul Gisbert Auwaerter, M.D.
Director
Mr. Michael Kelliher
Director
Mr. David B. Musket
Director
Mr. Earl M. Collier, Jr
Director
Dr. Frank Litvack,M.D.
Chairman of the Board/Director
Mr. George W. Dunbar,Jr
Director
Dr. Linda Marban, PhD
CEO/Director/President
Mr. Anthony J. Bergmann, M.B.A.
CFO/Chief Accounting Officer
Ms. Karen G. Krasney, J.D.
Executive VP/General Counsel/Secretary
Ms. Karimah Es Sabar
Director
Ownership
Institution Holdings
Highbridge Capital Management, LLC
2,789,699 (8.956%)
Nippon Shinyaku Co Ltd
2,145,922 (8.325%)
Vanguard Group Inc
1,165,404 (3.741%)
Woodline Partners LP
909,542 (2.920%)
Vanguard Investments Australia Ltd
870,835 (2.796%)
BlackRock Inc
359,673 (1.155%)
Geode Capital Management, LLC
316,198 (1.015%)
Fidelity Management & Research Company LLC
290,676 (0.933%)
Susquehanna International Group, LLP
149,115 (0.479%)
Renaissance Technologies Corp
146,321 (0.470%)
Individual Holdings
Dr. Linda Marban, PhD
198,604 (0.786%)
Dr. Frank Litvack,M.D.
133,269 (0.517%)
Mr. David B. Musket
31,536 (0.122%)
Mr. Earl M. Collier, Jr
26,856 (0.104%)
Ms. Karen G. Krasney, J.D.
20,047 (0.081%)
Mr. George W. Dunbar,Jr
10,556 (0.042%)
Dr. Paul Gisbert Auwaerter, M.D.
5,000 (0.019%)
Mr. Anthony J. Bergmann, M.B.A.
2,381 (0.009%)
Funds Holdings
Vanguard Total Stock Market Index Fund
870,835 (2.796%)
Vanguard US Total Market Shares ETF
870,835 (2.796%)
Vanguard Institutional Extnd Mkt Idx Tr
355,464 (1.141%)
BlackRock Extended Equity Market
50,995 (0.164%)
Fidelity Series Total Market Index Fund
41,223 (0.132%)
NT Ext Equity Market Index Fund - L
27,676 (0.089%)
NT DJ US Complt Ttl Stk Mkt Idx Eq Strat
27,676 (0.089%)
NT Quality Small Cap Core
11,585 (0.037%)
NT Quality SCC US Fund - L
11,585 (0.037%)
Extended Equity Market Fund M
6,305 (0.020%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
